Following MSTR's Q1 earnings (which showed revenue beat at $124.3M vs $120.8M est.), the stock opened higher at $184.56. The May 8 expiry options have an IV of 85.52%, which is elevated but has likely compressed after the earnings event. This creates a favorable environment for selling premium as implied volatility typically declines post-event. The consensus analyst rating is "Buy" with a mean price target of ~$313-$316, indicating significant long-term upside. Recent analyst upgrades (B. Riley to $200 from $188) reinforce this view, suggesting a lower probability of a sharp, immediate decline.
| Side | Price | Filled | Realized P&L |
|---|---|---|
| Credit Open | -0.42 1 | -- Holding |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- OswaldFinger·05-07 14:43Revenue beat! Still watching the IV crush after ER.1Report